• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


1.8500 EUR 0.0380 2.01%

As of 08:00:00 ET on 12/24/2014.

Company Profile for NicOx SA (COX)

NicOx develops pharmaceuticals using recently discovered properties of nitric oxide. The Company develops drugs-candidates for the potential treatment of inflammatory, cardiometabolic and ophthalmological diseases. NicOx's lead compound naproxcinod is developed for the relief of the signs and symptoms of osteoarthritis.

Contact Information

NicOx SA

1681 Route Des Dolines
Taissounieres HB4 BP 313
Valbonne, 06560
Phone: 33-4-97-24-53-00
Fax: 33-4-97-24-53-99

Key Executives for NicOx SA (COX)

Michele GarufiChairman/CEO/Co-FounderEvelyne NguyenChief Financial Officer
Michael BergaminiExec VP/Chief Scientific OfcrPhilippe MasquidaExec VP/Mng Dir:European & Intl Ops
Gavin SpencerExec VP:Corporate DevelopmentDavide BuffoniManaging Director:Spain
Benito GuerraManaging Director:ItalyTorsten CorneliusManaging Director:Germany
Jean-Francois MazelierManaging Director:France

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil